aldesleukin

Type: Keyphrase
Name: aldesleukin
First reported Sep 15 2014 - Updated Sep 16 2014 - 1 reports

Ongoing Clinical Trials Actively Recruiting Patients With Intraocular Cancer

The information contained in this Clinical Trials Resource Guide includes actively recruiting clinical studies of children and adults with intraocular cancers. The studies include pilot, phase 0, phase I, phase II, and observational trials evaluating ... [Published The ASCO Post - Sep 15 2014]
First reported Sep 10 2014 - Updated Sep 10 2014 - 1 reports

Taking Care in Sunny Weather: Answers To Important Questions About Metastatic Melanoma

[(BPT) - With sunshine and warm weather upon many of us, it’s a particularly important time to familiarize yourself with metastatic melanoma, the most dangerous form of skin cancer. Here are answers to some frequently asked questions about the diseas ... [Published Hammond Daily Star - Sep 10 2014]
First reported Aug 29 2014 - Updated Aug 29 2014 - 1 reports

Taking Care in Sunny Weather: Answers To Important Questions About Metastatic Melanoma

(BPT) - With sunshine and warm weather upon many of us, it’s a particularly important time to familiarize yourself with metastatic melanoma, the most dangerous form of skin cancer. Here are answers to some frequently asked questions about the disease ... [Published ARA Content - Aug 29 2014]
First reported Jul 19 2014 - Updated Jul 19 2014 - 1 reports

Immunotherapy for Kidney Cancer

Joseph I. Clark, MD Immunotherapy, a type of treatment designed to enhance or restore the body’s ability to fight cancerous cells by activating the immune system, has long been a mainstay of treatment for kidney cancer, and continues to attract ... [Published News from Kidney Cancer Association - Jul 19 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 1 reports

Kidney specific tumor vaccine directed against kidney tumor antigen G-250

This invention provides an anti-cancer immunogenic agent(s) (e.g. vaccines) that elicit an immune response specifically directed against renal cell cancers expressing a G250 antigenic marker. Preferred immunogenic agents comprise a chimeric molecule comprising ... [Published PharmCast - Jun 20 2014]
First reported May 30 2014 - Updated May 31 2014 - 1 reports

PROCLAIM(SM) Patient Registry Data Show Extension of Overall Survival Benefits Beyond Complete and Partial Responders in Metastatic Renal Cell Carcinoma Patients Treated with High-Dose Interleukin-2 (HD IL-2)

CHICAGO, May 30, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that analysis of data from the PROCLAIMSM national patient registry retrospective cohort shows improved overall survival in metastatic RCC patients treated with high-dose ... [Published PR Newswire: General Business - May 30 2014]
First reported May 08 2014 - Updated May 08 2014 - 1 reports

Compositions and methods for delivering inhibitory oligonucleotides

The present invention features compositions and methods that make use of complexes comprising one or more inhibitory nucleic acids and a targeting polypeptide, wherein the targeting polypeptide consists of a cell surface receptor ligand. The compositions ... [Published PharmCast - May 08 2014]
First reported Apr 11 2014 - Updated Apr 11 2014 - 1 reports

Targeting of bone marrow neovasculature

Antibodies which bind an antigen of the bone marrow neovasculature in leukaemia patients, for use in treatment and diagnosis of leukaemia, in particular the treatment and diagnosis of acute myeloid leukaemia (AML).Description of the InventionThe present ... [Published PharmCast - Apr 11 2014]

More Content

All (9) | News (7) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Ongoing Clinical Trials Actively Recruiting Pat... [Published The ASCO Post - Sep 15 2014]
Taking Care in Sunny Weather: Answers To Import... [Published Hammond Daily Star - Sep 10 2014]
Taking Care in Sunny Weather: Answers To Import... [Published ARA Content - Aug 29 2014]
Immunotherapy for Kidney Cancer [Published News from Kidney Cancer Association - Jul 19 2014]
Kidney specific tumor vaccine directed against ... [Published PharmCast - Jun 20 2014]
PROCLAIM(SM) Patient Registry Data Show Extensi... [Published PR Newswire: General Business - May 30 2014]
Compositions and methods for delivering inhibit... [Published PharmCast - May 08 2014]
Targeting of bone marrow neovasculature [Published PharmCast - Apr 11 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Immunotherapy for Kidney Cancer [Published News from Kidney Cancer Association - Jul 19 2014]
Joseph I. Clark, MD Immunotherapy, a type of treatment designed to enhance or restore the body’s ability to fight cancerous cells by activating the immune system, has long been a mainstay of treatment for kidney cancer, and continues to attract ...
PROCLAIM(SM) Patient Registry Data Show Extensi... [Published PR Newswire: General Business - May 30 2014]
CHICAGO, May 30, 2014 /PRNewswire/ -- Prometheus Laboratories Inc. announced today that analysis of data from the PROCLAIMSM national patient registry retrospective cohort shows improved overall survival in metastatic RCC patients treated with high-dose ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.